Sign In
9 Jul 2021 09:04
FORM 38.5(a)
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 38.5(a) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS WITH RECOGNISED INTERMEDIARY STATUS AND DEALING IN A CLIENT-SERVING CAPACITY
1. KEY INFORMATION
Name of exempt principal trader | Citigroup Global Markets Limited |
Company dealt in | UDG Healthcare plc |
Class of relevant security to which the dealings being disclosed relate (Note 1) | €0.05 ordinary shares |
Date of dealing | 8 July 2021 |
2. DEALINGS (Note 2)
(a) Purchases and sales
Total number of relevant securities acquired | Highest price paid (Note 3) | Lowest price paid (Note 3) |
298,850 | GBP 10.7500 | GBP 10.5550 |
Total number of securities disposed | Highest price received (Note 3) | Lowest price received (Note 3) |
292,250 | GBP 10.7500 | GBP 10.5550 |
(b) Derivatives transactions (other than options transactions)
Product name, e.g. CFD | Nature of transaction (Note 4) | Number of relevant securities (Note 5) | Price per unit (Note 3) GBP |
TRS | Increasing Short Position | 63 | 10.7500 |
TRS | Increasing Short Position | 360 | 10.7300 |
TRS | Increasing Short Position | 231 | 10.7250 |
TRS | Increasing Short Position | 2,605 | 10.7200 |
TRS | Increasing Short Position | 1,046 | 10.7100 |
TRS | Increasing Short Position | 1,947 | 10.7000 |
TRS | Increasing Short Position | 171 | 10.6900 |
TRS | Increasing Short Position | 177 | 10.6700 |
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, e.g. call option | Writing, selling, purchasing, varying etc. | Number of securities to which the option relates (Note 5) | Exercise price | Type, e.g. American, European etc. | Expiry date | Option money paid/received per unit (Note 3) |
|
|
|
|
|
|
|
(ii) Exercising
Product name, e.g. call option | Number of securities | Exercise price per unit (Note 3) |
|
|
|
3. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and
any other person relating to the voting rights of any relevant securities under any option referred to
on this form or relating to the voting rights or future acquisition or disposal of any relevant securities
to which any derivative referred to on this form is referenced. If none, this should be stated.
Date of disclosure | 9 July 2021 |
Contact name | Damian Flanagan |
Telephone number | 00 44 (0) 2890409676 |
Name of offeree/offeror with which connected | Nenelite Limited - a company controlled by Clayton, Dubilier & Rice, LLC |
Nature of connection (Note 6) | Financial Advisor |
Follow the stocks
